For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250508:nRSH7855Ha&default-theme=true
RNS Number : 7855H Kromek Group PLC 08 May 2025
8 May 2025
Kromek Group plc
("Kromek" or the "Company" or the "Group")
Directorate Change
Kromek Group plc (AIM: KMK), a leading developer of radiation and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments, announces that Claire Burgess will be appointed as a Director, Chief
Financial Officer ("CFO") and Company Secretary of the Group and that Paul
Farquhar is retiring and will therefore resign as a Director, CFO and Company
Secretary of the Group, both with effect from 1 June 2025. Ms. Burgess will
join Kromek on 12 May 2025 to allow for a period of handover ahead of her
assuming her new role.
Claire Burgess has spent over 12 years in senior financial positions in
businesses in the UK and US, primarily in the engineering and technology
sectors. Most recently, Ms. Burgess was Financial Director of Advanced
Electric Machines Group Ltd ("AEM"), a designer and manufacturer of
magnet-free electric powertrain technologies. Other experience includes being
CFO of group companies JB Processing and TBGS Holdings and being responsible
for establishing and building the US subsidiaries, including the acquisition
of the Alabama White Marble Quarry. She is a qualified Fellow Chartered
Accountant, having begun her career as an auditor at Ernst & Young before
joining KPMG as a Corporate Finance Executive.
Rakesh Sharma OBE FREng, Chairman of Kromek, said: "On behalf of the Board, I
would like to thank Paul for his contribution to Kromek. The business is in a
fundamentally stronger position than when he joined, and we wish him all the
best for his retirement. I would also like to welcome Claire to Kromek and to
the Board. Her experience with growing technology and engineering-based
companies with international operations is well-suited to the Kromek of today.
We look forward to benefiting from her expertise as we continue to execute on
our strategy."
Other than as set out below, there are no other matters required to be
disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for
Companies as regards Ms. Burgess' appointment. Ms. Burgess does not have an
interest in the ordinary shares of the Group.
Claire Louise Burgess (née Dyson)
The following information regarding the appointment of Claire Burgess, aged
51, is disclosed under Schedule 2(g) of the AIM Rules for Companies:
Current directorships and/or partnerships Former directorships and/or partnerships (within the last 5 years)
Advanced Electric Machines Group Limited
Advanced Electric Machines Limited
Advanced Electric Machines Research Limited
Inn Collection (Bassenthwaite) Limited
Inn Collection Lakes (Ambleside) Limited
Inn Collection (Whitby) Limited
Inn Collection (Northallerton) Limited
Inn Collection (Helmsley) Limited
Inn Collection (Seaburn) Limited
Inn Collection Lakes (Coniston) Limited
Vindolanda Bidco Limited
Lindisfarne Inns Limited
Inn Collection Limited
Inn Collection AcquisitionCo Limited
Inn Collection Topco Limited
Inn Collection Midco Limited
Durham Vale Developments Limited
Vindolanda Midco 1 Limited
Marshall Inns Limited
Greensfield Moor Development Limited
Lindisfarne Inns (Bamburgh Castle) Limited
Inn Collection Bidco Limited
Vindolanda Topco Limited
Vindolanda Midco 2 Limited
Inn Collection Management Limited
Inn Collection Lakes (Ambleside) Limited
Ms. Burgess does not hold any shares in Kromek.
There are no further disclosures to be made under Rule 17 and Schedule 2(g) of
the AIM Rules for Companies.
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO +44 (0)1740 626 060
Paul Farquhar, CFO
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance +44 (0)20 7220 0500
Tim Redfern - ECM
Michael Johnson - Sales
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury/Henry Gamble +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.
The advanced imaging segment comprises the medical (including CT and SPECT),
security and industrial markets. Kromek provides its OEM customers with
detector components, based on its core cadmium zinc telluride (CZT) platform,
to enable better detection of diseases such as cancer and Alzheimer's,
contamination in industrial manufacture and explosives in aviation
settings.
In CBRN detection, the Group provides nuclear radiation detection solutions to
the global homeland defence and security market. Kromek's compact, handheld,
high-performance radiation detectors, based on advanced scintillation and
solid-state readout technology, are primarily used to protect critical
infrastructure, events, personnel and urban environments from the threat of
'dirty bombs'.
The Group is also developing bio-security solutions in the CBRN detection
segment. These consist of fully automated and autonomous systems to detect a
wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange, under the
trading symbol 'KMK'.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAFFFFLEAIDIIE